Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers

NCT02117245 is registered in ClinicalTrials.gov with Mirati Therapeutics Inc. as lead sponsor.

NCT NCT02117245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers
Lead sponsor
Mirati Therapeutics Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
November 30, 2012
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy